Cart
sales@molnova.com
β-catenin-IN-2
CAS No. 1458664-10-2
β-catenin-IN-2( —— )
Catalog No. M28838 CAS No. 1458664-10-2
β-catenin-IN-2 is a potent inhibitor of β-catenin that can be used in colorectal cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 264 | In Stock |
|
| 5MG | 227 | In Stock |
|
| 10MG | 359 | In Stock |
|
| 25MG | 607 | In Stock |
|
| 50MG | 849 | In Stock |
|
| 100MG | 1144 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2316 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nameβ-catenin-IN-2
-
NoteResearch use only, not for human use.
-
Brief Descriptionβ-catenin-IN-2 is a potent inhibitor of β-catenin that can be used in colorectal cancer research.
-
Descriptionβ-catenin-IN-2 is a potent inhibitor of β-catenin that can be used in colorectal cancer research.(In Vitro):In HCT116 cells, β-catenin-IN-2 (10-40 μM) dose-dependently suppressed the transcriptional activity of the β-catenin/Tcf-4 .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorH4 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1458664-10-2
-
Formula Weight255.29
-
Molecular FormulaC15H14FN3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (326.41 mM)
-
SMILESCN(C)c(cc1)ccc1-c1nc(ccc(F)c2)c2[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sanna MD, et al. Histamine H4 receptor stimulation in the locus coeruleus attenuates neuropathic pain by promoting the coeruleospinal noradrenergic inhibitory pathway. Eur J Pharmacol. 2020 Feb 5;868:172859.
molnova catalog
related products
-
L-quebrachitol
L-quebrachitol is a natural product.L-quebrachitol may promote osteoblastogenesis by triggering the BMP-2-response as well as the Runx2 MAPK and Wnt/β-catenin signaling pathway.
-
DIF-3
DIF-3 is a chemical compound that acts by activating GSK-3β to facilitate the degradation of cyclin D1 and c-Myc, resulting in reduced expression levels of these proteins.
-
WWL70
WWL70 is a selective alpha/beta hydrolase domain 6 inhibitors (IC50: 70 nM). WWL70 (10 μM, 1 h) treatment, 2-Arachidonoylglycerol is increased by 20% compared to untreated cells.
